Skip to content

ROMETHEUS

Active
Private limited companyfounded 2022active for 4 yearsZandstraat 93, 2300 Turnhout, BelgiumKBO/BCE: BE 0780.395.979
Summary

The annual accounts of ROMETHEUS for financial year 2025 show a net loss of 62% of total assets and of 57% of the equity at the start of that year. The 2025 annual accounts show equity of €4,189 and a net result of -€5,510. Equity is shrinking by about 38% per year and would, assuming unchanged policy, indicatively turn negative around financial year 2027. Its solvency ranks better than 37% of 20,643 sector peers (NACE 86, financial year 2025). The company has been active since 2022 and the Belgian Official Gazette contains no insolvency or warning signals. The computed 12-month bankruptcy probability is 0.3% (very low).

Overview

Activity
Physiotherapy
NACE 86951
1 site
Size
€8,921total assets 2025
Equity
€4,189
Loss
-€5,510
Turnover not published (micro format)
Financial health
53 Fair Checked score 2025
Bankruptcy probabilitywithin 12 months
0.3%
Structure
2025 accounts 2 days early1 deed in the Belgian Official Gazette
Why 53raises riskCapped at 59: a net loss of at least half of total assets or of the equity at the start of the financial yearLiquidity: current ratio 1.96, cash €0, halvedlowers riskSector: Human health activities (NACE 86)Size: total assets €8,921Figures for financial year 2025 (filed 29-07-2026)Show the evidence

Checked score

Score 2025
53 / 100
Fair
Probability in this band: 1.5% to 4.2%
Financially better than 14% of its sector peers (NACE 86, micro)
A net loss of at least half of total assets or of the equity at the start of the financial year caps the score at 59. Every signal that counts is listed under Signals.
Financial strength · tick = 2024
Weak
Solvency 72-26
equity 47.0% of total assets
Liquidity 27-14
short-term debt 46.2% · cash 0.0%
Profitability 0=
return on assets -61.8%
Bankruptcy probability, 12 months
0.3% Very low
0%0.5%1.5%4%10%≥ 25%

About 3 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,138 companies, NACE 86, micro)
Last 24 months 11-2024: < 0.1%lowest value 12-2024: < 0.1%● unchanged vs 11-2024lowest value 01-2025: < 0.1%● unchanged vs 12-2024lowest value 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: 0.1%▲ +0.1 percentage points vs 07-2025 09-2025: 0.2%▲ +0.1 percentage points vs 08-2025 10-2025: 0.2%● unchanged vs 09-2025 11-2025: 0.2%● unchanged vs 10-2025 12-2025: 0.2%● unchanged vs 11-2025 01-2026: 0.2%● unchanged vs 12-2025 02-2026: 0.2%● unchanged vs 01-2026 03-2026: 0.2%● unchanged vs 02-2026 04-2026: 0.2%● unchanged vs 03-2026 05-2026: 0.2%● unchanged vs 04-2026 06-2026: 0.3%▲ +0.1 percentage points vs 05-2026 07-2026: 0.3%● unchanged vs 06-2026highest value 08-2026: 0.3%● unchanged vs 07-2026 09-2026: 0.3%● unchanged vs 08-2026 10-2026: 0.3%● unchanged vs 09-2026
No publishable credit limit; credit only on tighter terms
Net loss of at least half of total assets or of the equity at the start of the financial year.
Liquidity ample (current ratio 1.96, compared with 3.34 in 2024, above the usual 1.5; short-term debt: 46.2% and cash: 0% of total assets), but 53% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro): better than 38% on solvency, 5% on liquidity, 1% on profitability and 11% on growth.

The bankruptcy probability was computed on 28-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Six signals.
lowers riskraises riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
raises risk · Liquidity: current ratio 1.96, cash €0, halved
NBB · annual accounts
lowers risk · Size: total assets €8,921
Companies of this size fail less often; how much that weighs depends on the rest of its profile.
NBB · annual accounts
lowers risk · Figures for financial year 2025 (filed 29-07-2026)
NBB · annual accounts
raises risk · Persistent losses
Two consecutive loss-making years (2024 and 2025); equity is also lower. May indicate structural pressure on profitability.
NBB · annual accounts 2025
Net result per financial year
22232425
2022 to 2025 · latest year -€5,510
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 29-07-2026, 2 days ahead of the deadline.
NBB · 4 filings
Deviation from the deadline
2025
2 days early
2024
1 day early
2023
6 days early
2022
48 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 4 accounts on average 14 days before the deadline; the sector median (NACE 86) for financial year 2024 is 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 28 July (3 of the last 4 filed years within 30 days of that day).
Companies Code · seven months
Where today falls in the filing period
29-10-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since incorporation in 2022.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2025 · micro…
  2. Annual accounts filedfinancial year 2024 · micro…
  3. Weakest financial yearnet -€6,215

Financials · financial year 2025, micro format

Equity
€4,189▼ 56.8%
2024 · €9,698
Total assets
€8,921▼ 32.5%
2024 · €13,220
Net result
-€5,510▲ 11.4%
2024 · -€6,215
Working capital
€3,955▼ 52.1%
2024 · €8,256
Trend over the years

2022 to 2025, 4 financial years

The operating result stays negative: a loss of €5,051 in 2025 against €5,673 in 2024; the loss shrinks.

What the company sold each financial year and what was left of it. A loss stands below the zero line.

Operating result-€5,051 2025 Net result-€5,510 2025

Use the arrow keys on the chart for the figures per year.

Sector: the middle half of NACE 86, Human health activities: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30. Dashed line: the median. Available for Net result, Equity, Total assets, Working capital, Solvency, Current ratio, Return on assets (ROA).

Every figure with its change against the financial year before
favourable unfavourable
Line2022202320242025
Operating result€11,322-€9,940▼ 12.2%-€5,673-€5,051▲ 11.0%
Net result€6,980below the sector's middle half-€6,434below the sector's middle half▼ 7.8%-€6,215below the sector's middle half-€5,510below the sector's middle half▲ 11.4%
Equity€9,480below the sector's middle half-€15,914below the sector's middle half▲ 67.9%€9,698below the sector's middle half▼ 39.1%€4,189below the sector's middle half▼ 56.8%
Total assets€36,753below the sector's middle half-€20,721below the sector's middle half▼ 43.6%€13,220below the sector's middle half▼ 36.2%€8,921below the sector's middle half▼ 32.5%
Debt€27,273-€4,807▼ 82.4%€3,521▼ 26.7%€4,732▲ 34.4%
Working capital€6,839below the sector's middle half-€13,872below the sector's middle half▲ 103%€8,256below the sector's middle half▼ 40.5%€3,955below the sector's middle half▼ 52.1%
Solvency25.8%below the sector's middle half-76.8%within the sector's middle half▲ 51.0pp73.4%within the sector's middle half▼ 3.4pp47.0%within the sector's middle half▼ 26.4pp
Current ratio1.25below the sector's middle half-3.89within the sector's middle half▲ 2.643.34within the sector's middle half▼ 0.541.96within the sector's middle half▼ 1.39
Return on assets (ROA)19.0%within the sector's middle half-31.1%within the sector's middle half▲ 12.1pp-47.0%below the sector's middle half▼ 78.1pp-61.8%below the sector's middle half▼ 14.7pp
above within below the middle half of NACE 86, Human health activities: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30.
Turnover and EBIT margin not published: the micro format does not require them.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €8,921
Fixed assets €843 ▼ 41.5%
Current assets €8,077 ▼ 31.4%
Equity and liabilities €8,921
Equity €4,189 ▼ 56.8%
Debt €4,732 ▲ 34.4%
Debt's share of the balance-sheet total rises from 26.6% to 53.0%. Equity is lower and debt is higher.
Key figures and ratios
2025 value · change against 2024
EBITDA
-€4,452▲
2024 · -€5,074
Cash flow
-€4,911▲
2024 · -€5,616
Quick ratio
1.29▼
2024 · 2.56
Debt to equity
1.13▲
2024 · 0.36
ROE
-131.5%▼
2024 · -64.1%
Interest coverage
-9.70▼
2024 · -8.86
Debt ≤ 1 year
€4,122▲
2024 · €3,521
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.

Peer companies

Historical observation

Of the 3,223 companies that looked in July 2024 the way this one looks now, 3.4% went bankrupt within 24 months and 87.8% are still going.

  • Micro
  • 2 to 5 years old
  • solvency 30% or more
  • a loss of 10% of the balance sheet or more
3.4% went bankrupt
8.7% stopped otherwise
87.8% still going

A further 0.2% stopped, but we cannot tell whether within those 24 months.

For this company itself Checked computes a lower bankruptcy probability: 0.3% over twelve months. The score reads more about this company than the group's four characteristics; both figures are right about what they measure.

How reliable is this rule?

Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,445 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.

The companies in ten equal groups, from lowest to highest expected share.
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 3.0% 3.1%
10 5.6% 6.2%

The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74.5% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.

An observation about 3,223 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.

Annual accounts
Filed annual accounts As filed with the NBB · 2025 against 2024 · 40 lines
Balance sheet Code20242025
Assets
Total assets20/58€13,220€8,921▼
Fixed assets21/28€1,442€843▼
Intangible fixed assets21€1,442€843▼
Current assets29/58€11,777€8,077▼
Stocks and contracts in progress3€2,750€2,750=
Stocks30/36€2,750€2,750=
Amounts receivable within one year40/41€8,911€5,327▼
Trade receivables40€6,526€4,706▼
Other amounts receivable41€2,385€621▼
Cash at bank and in hand54/58€116€0▼
Equity and liabilities
Total equity and liabilities10/49€13,220€8,921▼
Equity10/15€9,698€4,189▼
Contributions10/11€2,500€2,500=
Reserves13€6,980€6,980=
Distributable reserves133€6,980€6,980=
Profit (loss) carried forward14€219-€5,291▼
Amounts payable17/49€3,521€4,732▲
Amounts payable within one year42/48€3,521€4,122▲
Financial debts43-€1,348
Credit institutions430/8-€1,348
Trade debts44€903€1,437▲
Suppliers440/4€903€1,437▲
Taxes, remuneration and social security45€1,989€0▼
Taxes450/3€1,989€0▼
Other amounts payable47/48€629€1,337▲
Accrued charges and deferred income492/3-€610
Income statement Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€599€599=
Other operating charges640/8€1,224€610▼
Gross operating margin9900-€3,850-€3,842▲
Operating profit (loss)9901-€5,673-€5,051▲
Financial income75/76B€30€0▼
Recurring financial income75€30€0▼
Financial charges65/66B€573€459▼
Recurring financial charges65€573€459▼
Profit (loss) for the period before taxes9903-€6,215-€5,510▲
Income taxes67/77€0-
Profit (loss) for the period9904-€6,215-€5,510▲
Profit (loss) for the period to be appropriated9905-€6,215-€5,510▲
Appropriation of the result
Profit (loss) to be appropriated9906€219-€5,291▼
Profit (loss) brought forward from the previous period14P€6,434€219▼

The notes to these accounts (4 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line2022202320242025Change
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€355€599€599€599=
Other operating charges640/8€1,680€211€1,224€610▼ 50.2%
Gross operating margin9900€13,356€10,750-€3,850-€3,842▲ 0.2%
Operating profit (loss)9901€11,322€9,940-€5,673-€5,051▲ 11.0%
Financial income75/76B€0€0€30€0▼ 100%
Recurring financial income75€0€0€30€0▼ 100%
Financial charges65/66B€1,351€1,517€573€459▼ 19.9%
Recurring financial charges65€1,351€1,517€573€459▼ 19.9%
Profit (loss) for the period before taxes9903€9,971€8,423-€6,215-€5,510▲ 11.4%
Income taxes67/77€2,991€1,989€0--
Profit (loss) for the period9904€6,980€6,434-€6,215-€5,510▲ 11.4%
Profit (loss) for the period to be appropriated9905€6,980€6,434-€6,215-€5,510▲ 11.4%
Line2022202320242025Change
Assets
Total assets20/58€36,753€20,721€13,220€8,921▼ 32.5%
Fixed assets21/28€2,640€2,041€1,442€843▼ 41.5%
Intangible fixed assets21€2,640€2,041€1,442€843▼ 41.5%
Current assets29/58€34,112€18,679€11,777€8,077▼ 31.4%
Stocks and contracts in progress3€3,750€2,750€2,750€2,750=
Stocks30/36€3,750€2,750€2,750€2,750=
Amounts receivable within one year40/41€22,118€9,210€8,911€5,327▼ 40.2%
Trade receivables40€20,109€6,673€6,526€4,706▼ 27.9%
Other amounts receivable41€2,009€2,537€2,385€621▼ 74.0%
Cash at bank and in hand54/58€8,245€6,720€116€0▼ 100%
Equity and liabilities
Total equity and liabilities10/49€36,753€20,721€13,220€8,921▼ 32.5%
Equity10/15€9,480€15,914€9,698€4,189▼ 56.8%
Contributions10/11€2,500€2,500€2,500€2,500=
Reserves13€6,980€6,980€6,980€6,980=
Distributable reserves133€6,980€6,980€6,980€6,980=
Profit (loss) carried forward14-€6,434€219-€5,291-
Amounts payable17/49€27,273€4,807€3,521€4,732▲ 34.4%
Amounts payable within one year42/48€27,273€4,807€3,521€4,122▲ 17.1%
Financial debts43€25,000€0-€1,348-
Credit institutions430/8---€1,348-
Other loans439€25,000€0---
Trade debts44€94€289€903€1,437▲ 59.0%
Suppliers440/4€94€289€903€1,437▲ 59.0%
Taxes, remuneration and social security45€782€1,989€1,989€0▼ 100%
Taxes450/3€782€1,989€1,989€0▼ 100%
Other amounts payable47/48€1,398€2,529€629€1,337▲ 113%
Accrued charges and deferred income492/3---€610-
Line2022202320242025Change
Profit (loss) for the period9904€6,980€6,434-€6,215-€5,510▲ 11.4%
+ Depreciation and write-downs630€355€599€599€599=
Operating cash flow (approximation)€7,334€7,033-€5,616-€4,911▲ 12.6%
Investment in fixed assets (approximation)-€0€0€0-
Change in cash--€1,525-€6,603-€116▲ 98.2%

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Filings with the National Bank (4)
Financial year Type Filed Reference
31-12-2025 micro format 29-07-2026 2026-00351983
31-12-2024 micro format 30-07-2025 2025-00353732
31-12-2023 micro format 25-07-2024 2024-00309298
31-12-2022 micro format 13-06-2023 2023-00121920

Similar companies · same sector, comparable size

Of the 12,614 active companies whose main activity is physiotherapy (NACE 86951), figures are known for 2,250. 1,015 are within a factor 10 of this equity. These 5 are the closest to it. See the whole sector

Subsidies and aid

Flemish government

2022 · 1 entry · €569 awarded · €569 paid
Schemes
1 entry · €569 · €569 paid · Fonds voor Innoveren en Ondernemen

Public contracts: No European public contracts awarded found since October 2016. Contracts below the EU thresholds are not in TED.

Directors

Directors
No directors read yet: 0 of 1 Gazette act processed. See the directors and other office holders in the KBO →

Owners and capital

Owners

No owners or capital events in the accounts and acts we read.

History

ROMETHEUS was incorporated on 13 January 2022 as a private limited company.1 Total assets fell from €36,753 in 2022 to €8,921 in 2025.2

  1. 1KBO register
  2. 2National Bank, annual accounts 2022 and 2025

Acts, filings and financial milestones

Next filing, financial year 2026, expected by 31-07-2027
2026
29-07
NBB filing Annual accounts filed
financial year 2025 · micro format
2025
30-07
NBB filing Annual accounts filed
financial year 2024 · micro format
2024
31-12
Financial Weakest financial yearnet -€6,215
Net result drops to -€6,215, the lowest in the series; recovery starts the following year.
25-07
NBB filing Annual accounts filed
financial year 2023 · micro format
2023
31-12
Financial Liquidity more than triplescurrent ratio 3.89
Current ratio from 1.25 to 3.89; short-term debt falls from €27,273 to €4,807.
13-06
NBB filing Annual accounts filed
financial year 2022 · micro format
Financial milestoneNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
0 of 1 deed read
About the unread acts

We know of 1 Belgian Official Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Register details

Identification
Legal formPrivate limited company
Founded13-01-2022
Financial year end31-12
Activities, NACEBEL 2025
86951Physiotherapy
46460Wholesale of pharmaceutical and medical goods
E-invoicing
Reachable via Peppol
Peppol ID 0208:0780395979
Also 9925:BE0780395979
Registered 31-10-2023

If you follow this company, Checked tells you the day it leaves the Peppol register.

Register as of 29 October 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.

Environmental permits: No permit applications found in Flanders. Brussels and Wallonia do not publish the applicant.

Sites & property

Location & real-estate footprint
Registered office, Turnhout · 1 establishment unit since 2022
registered office establishment The establishment unit on the map
Ground area
295 m²
Building footprint
105 m²
Building volume
543 m³
Parcel 13453O0424/00B006, Flanders · tallest building 10.6 m. Linked by address, not a title deed.
1 establishment unit
ROMETHEUS
Zandstraat 93, 2300 TurnhoutPhysiotherapy
since 2022unit no. 2.327.203.808
1 parcel
Flanders 1 (100%)
Cadastral parcel Region Area Buildings Height / floors
13453O0424/00B006 Flanders 295 m² 1 · 105 m² 10.6 m · 2
How the parcels are linked
Good to know
The parcel matches the address exactly.